Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001157523-10-002542
Filing Date
2010-04-29
Accepted
2010-04-29 16:49:25
Documents
3
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 ORE PHARMACEUTICAL HOLDINGS INC. 10-K/A a6267935.htm 10-K/A 372759
2 EXHIBIT 31.1 a6267935ex31-1.htm EX-31.1 6122
3 EXHIBIT 31.2 a6267935ex31-2.htm EX-31.2 6078
  Complete submission text file 0001157523-10-002542.txt   386641
Mailing Address ONE MAIN STREET SUITE 300 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 300 CAMBRIDGE MA 02142 6176492001
ORE PHARMACEUTICAL HOLDINGS INC. (Filer) CIK: 0001043914 (see all company filings)

EIN.: 061411336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-23317 | Film No.: 10782363
SIC: 2835 In Vitro & In Vivo Diagnostic Substances